<DOC>
	<DOCNO>NCT02551302</DOCNO>
	<brief_summary>Effectiveness hybrid system ( `` top '' ) compare rigid spondylodesis fusion surgery lumbar spine : A prospective , randomize , bicentric pilot study ( `` CD HORIZON BalanC™ )</brief_summary>
	<brief_title>`` Efficacy Hybrid Systems ( `` Topping Off '' ) Versus Rigid Spinal Fusion Lumbar Fusion Surgery : A Dual-center , Prospective , Randomized Pilot Study ( `` CD Horizon BalanC '' ) ''</brief_title>
	<detailed_description>Posterior spondylodesis monosegmental intervertebral cage plus flexible spondylodesis superiorly adjacent segment ( CD HORIZON BalanC™ Manufacturer : Medtronic ) Control : Posterior spondylodesis monosegmental intervertebral cage</detailed_description>
	<criteria>Informed consent Legal capacity Age ≥ 30 year Indication monosegmental lumbar spine fusion ( PLIF `` toppingoff `` ) L2S1 osteochondrosis Modic grade IIII [ 20 ] [ 21 ] [ 22 ] spondylolisthesis Meyerding grade IIII . Radiologic sign degeneration adjacent segment intend fusion without sign instability Motor deficit Cauda equina syndrome Previous surgical intervention lumbar spine Relevant peripheral neuropathy Acute denervation subsequent radiculopathy Scoliosis Cobb angle great 25° Spondylolisthesis &gt; Meyerding grade III Radiologic sign degeneration adjacent segment intend fusion sign instability ( definition , see inclusion criterion ) No radiologic sign degeneration adjacent segment intend fusion ( definition , see inclusion criterion ) Radiologic sign degeneration adjacent segment intend fusion &gt; Fujiwara grade II [ 15 ] &gt; Pfirrmann grade IV [ 14 ] Signs instability lumbar spine segment undergo fusion General contraindication elective lumbar spine surgery Pathologic fracture Osteoporosis pathologic fracture Active systemic infection Rheumatic disease Disease bone metabolism ( e.g . Paget 's Disease ) Bone metastasis Local infection focus lumbar spine Seizure disorder Chronic ischemia Fontaine classification IIbIV Severe heart insufficiency ( NYHA IIIIV ) Blood coagulation disorder blood thin therapy Cortisone intake one month last 12 month randomization Simultaneous participation another clinical trial 30 day randomization Known allergy intolerance implant Dependency investigator Lack familiarity German language Placement institution governmental juridical advice Absent legal capacity Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>